Showing results (591-600 of 866) with videos related to
Sort By:
Pageof 87
Med (New York, N.Y.)|May 9, 2026
CTHRC1+ fibroblasts in intestinal fibrosis in Crohn's disease: A done deal?Meiqi Yang, Zhanju LiuMed (New York, N.Y.)|May 7, 2026
Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trialJiliang Qiu, Zhenkun Huang, Wei He, et al.Med (New York, N.Y.)|June 3, 2026
The thyroid-liver axis in MASLD: From metabolic control to clinical translationYasmina Chouik, Cyrielle Caussy, Frank TackeMed (New York, N.Y.)|July 11, 2022
Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the BA.1 and BA.2 Omicron variantsYohei Seki, Yasuo Yoshihara, Kiyoko Nojima, et al.Med (New York, N.Y.)|October 14, 2023
Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patientsTimothée Bruel, Lou-Léna Vrignaud, Françoise Porrot, et al.Med (New York, N.Y.)|June 12, 2026
Therapeutic development in MASH: From accelerated approval to cirrhosis trial innovationWinston Dunn, Naim AlkhouriMed (New York, N.Y.)|May 28, 2026
Rethinking healthcare data interoperability in the age of large language modelsGeorg von Arnim, Severin Kohler, Stefan Hegselmann, et al.Med (New York, N.Y.)|June 12, 2026
Moving beyond associations: The role of mechanistic evidence in prenatal paracetamol safetyAthina Samara, Asma KhalilMed (New York, N.Y.)|May 19, 2022
Progress and opportunities for women in clinical trials: A look at recent data and initiatives from the U.S. FDAKaveeta P Vasisht, Bridget M Nugent, Janet WoodcockMed (New York, N.Y.)|January 10, 2022
Artemisinin resistance in Africa: How urgent is the threat?David A Fidock, Philip J RosenthalPageof 87